Scribd Logo
Upload

Welcome to Scribd!

  • Faculty AIUM2018

    Uploaded by

    Ahmed H. Ali Elbestawey
    12 views1 page
    Ultrasound and biomarkers can be used between 11-14 weeks of pregnancy to screen for fetal abnormalities. Screening with ultrasound examines fetal anatomy and growth, while biomarkers from maternal blood provide additional risk information. Together, ultrasound and biomarkers in this gestational period allow for more accurate screening than either method alone.

    Original Description:

    Original Title

    FacultyAIUM2018

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Ultrasound and biomarkers can be used between 11-14 weeks of pregnancy to screen for fetal abnormalities. Screening with ultrasound examines fetal anatomy and growth, while biomarkers from maternal blood provide additional risk information. Together, ultrasound and biomarkers in this gestational period allow for more accurate screening than either method alone.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    12 views1 page

    Faculty AIUM2018

    Uploaded by

    Ahmed H. Ali Elbestawey
    Ultrasound and biomarkers can be used between 11-14 weeks of pregnancy to screen for fetal abnormalities. Screening with ultrasound examines fetal anatomy and growth, while biomarkers from maternal blood provide additional risk information. Together, ultrasound and biomarkers in this gestational period allow for more accurate screening than either method alone.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    The Role of Ultrasound and Biomarkers

    at 11-14 weeks: A comprehensive review

    You might also like